In a report released today, Emily Field from Barclays maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target of £14.50. The company’s shares opened today at ...
Bearish flow noted in GSK (GSK) Pharma with 6,103 puts trading, or 5x expected. Most active are 3/14 weekly 39.5 puts and Mar-25 41.5 calls, with total volume in those strikes near 5,500 contracts.
GlaxoSmithKline has found a replacement for head of vaccines R&D Emmanuel Hanon, who left the company for a US biotech earlier this year, hiring Phil Dormitzer from ...
GSK has claimed its second breakthrough designation from the FDA for antibody-drug conjugate GSK5764227, which it licensed from China's Hansoh Pharma in a $1.7 billion deal. The status has been ...
A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. We're maintaining the criteria we used for last ...
After hours: March 14 at 7:47:25 PM EDT Loading Chart for GSK ...
Copyright © 2025 MarketWatch, Inc. All rights reserved.
13th Mar 2025 7:00 am RNS Transaction in Own Shares 12th Mar 2025 7:00 am RNS Transaction in Own Shares 11th Mar 2025 7:00 am RNS Transaction in Own Shares 10th Mar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback